{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T01:32:30Z","timestamp":1785461550666,"version":"3.56.0"},"reference-count":57,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Clin Neuropharm"],"published-print":{"date-parts":[[2023,11]]},"abstract":"<jats:sec>\n            <jats:title>Objectives<\/jats:title>\n            <jats:p>Acute traumatic brain injury is one of the most common causes of death and disability. Reduction in the level of consciousness is a significant complication that can impact morbidity. Glasgow Coma Scale (GCS) is the most widely used method of assessing the level of consciousness. Neurostimulants such as amantadine and modafinil are common pharmacologic agents that increase GCS in patients with brain trauma. This study aimed to compare the effectiveness of these 2 drugs.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>This systematic review obtained articles from Google Scholar, PubMed, Scopus, Embase, and MEDLINE databases. Extensive searches were conducted separately by 4 individuals in 3 stages. Ultimately, 16 clinical trials, cohort studies, case reports, and case series articles were obtained after reading the title, abstract, and full text and considering the exclusion criteria. The data of the final article were entered into the analysis table. This study was registered with PROSPERO (registration number CRD42022334409) and conducted in accordance with Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Amantadine seems to be associated with a higher overall response rate. In contrast, modafinil is associated with the most remarkable change in GCS score during treatment. However, the number of clinical trials with high quality and sample size has not been satisfactory to compare the effectiveness of these 2 drugs and their potential side effects.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>The authors recommend additional double-blind clinical trials are needed to be conducted with a larger sample size, comparing amantadine with modafinil to delineate the efficacy and adverse effects, both short and long term.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/wnf.0000000000000577","type":"journal-article","created":{"date-parts":[[2023,10,18]],"date-time":"2023-10-18T20:04:50Z","timestamp":1697659490000},"page":"229-238","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":4,"title":["Consciousness Recovery in Traumatic Brain Injury: A Systematic Review Comparing Modafinil and Amantadine"],"prefix":"10.1097","volume":"46","author":[{"given":"Ali","family":"Seifi","sequence":"first","affiliation":[{"name":"Department of Neurosurgery, UT Health, San Antonio, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sina","family":"Hassannezhad","sequence":"additional","affiliation":[{"name":"Neurosciences Research Center (NSRC), Tabriz University of Medical Sciences, Tabriz, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reza","family":"Mosaddeghi-Heris","sequence":"additional","affiliation":[{"name":"Neurosciences Research Center (NSRC), Tabriz University of Medical Sciences, Tabriz, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arash","family":"Haji Kamanaj Olia","sequence":"additional","affiliation":[{"name":"Neurosciences Research Center (NSRC), Tabriz University of Medical Sciences, Tabriz, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Adib","sequence":"additional","affiliation":[{"name":"Neurosciences Research Center (NSRC), Tabriz University of Medical Sciences, Tabriz, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaheryar","family":"Hafeez","sequence":"additional","affiliation":[{"name":"Division of Neuro Critical Care, Department of Critical Care Medicine, University of Pittsburgh Medical Center, Pittsburgh, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colleen","family":"Barthol","sequence":"additional","affiliation":[{"name":"Department of Pharmacotherapy and Pharmacy Services, University Health System of San Antonio, San Antonio, TX."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2023,10,19]]},"reference":[{"issue":"2","key":"bib2-20250621","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1177\/0033354916687748","article-title":"Traumatic brain injury incidence, clinical overview, and policies in the US military health system since 2000","volume":"132","year":"2017","journal-title":"Public Health Rep"},{"issue":"2","key":"bib3-20250621","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1176\/appi.psy.41.2.95","article-title":"Neuropsychiatric sequelae of traumatic brain injury","volume":"41","year":"2000","journal-title":"Psychosomatics"},{"issue":"2","key":"bib5-20250621","doi-asserted-by":"crossref","first-page":"niab047","DOI":"10.1093\/nc\/niab047","article-title":"Consciousness as a multidimensional phenomenon: implications for the assessment of disorders of consciousness","volume":"2021","year":"2021","journal-title":"Neurosci Conscious"},{"issue":"3","key":"bib6-20250621","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1097\/00001199-199309000-00010","article-title":"Definition of mild traumatic brain injury","volume":"8","year":"1993","journal-title":"J Head Trauma Rehabil"},{"issue":"9233","key":"bib7-20250621","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/S0140-6736(00)02689-1","article-title":"Traumatic brain injury","volume":"356","year":"2000","journal-title":"Lancet"},{"key":"bib8-20250621","first-page":"173","article-title":"Neuropsychiatric sequelae: assessment and pharmacologic intervention","volume":"14","year":"1999","journal-title":"Trauma Brain Inj"},{"issue":"10","key":"bib9-20250621","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1001\/jama.282.10.974","article-title":"Rehabilitation of persons with traumatic brain injury","volume":"282","year":"1999","journal-title":"JAMA"},{"issue":"4","key":"bib10-20250621","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/BF01108414","article-title":"Cognitive effects of mild head injury in children and adolescents","volume":"3","year":"1992","journal-title":"Neuropsychol Rev"},{"issue":"6","key":"bib11-20250621","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1017\/S1355617797005559","article-title":"Age-related differences in outcomes following childhood brain insults: an introduction and overview","volume":"3","year":"1997","journal-title":"J Int Neuropsychol Soc"},{"issue":"5","key":"bib12-20250621","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1097\/00004583-200105000-00017","article-title":"Lifetime and novel psychiatric disorders after pediatric traumatic brain injury","volume":"40","year":"2001","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"11","key":"bib13-20250621","first-page":"1045","article-title":"Subacute to chronic mild traumatic brain injury","volume":"86","year":"2012","journal-title":"Am Fam Physician"},{"issue":"6","key":"bib14-20250621","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1001\/archneur.1991.00530180032013","article-title":"Vegetative state after closed-head injury: a traumatic coma data bank report","volume":"48","year":"1991","journal-title":"Arch Neurol"},{"issue":"21","key":"bib15-20250621","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1056\/NEJM199405263302107","article-title":"Medical aspects of the persistent vegetative state","volume":"330","year":"1994","journal-title":"N Engl J Med"},{"issue":"2","key":"bib16-20250621","doi-asserted-by":"crossref","first-page":"187","DOI":"10.3109\/02688697.2013.841845","article-title":"Therapeutic options to enhance coma arousal after traumatic brain injury: state of the art of current treatments to improve coma recovery","volume":"28","year":"2014","journal-title":"Br J Neurosurg"},{"issue":"3","key":"bib17-20250621","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1037\/0090-5550.51.3.232","article-title":"Use of the Neuropsychiatric Inventory in traumatic brain injury: a pilot investigation","volume":"51","year":"2006","journal-title":"Rehabil Psychol"},{"issue":"2","key":"bib18-20250621","doi-asserted-by":"crossref","first-page":"E19","DOI":"10.1097\/HTR.0b013e31828dc590","article-title":"Prevalence, comorbidities, and correlates of challenging behavior among community-dwelling adults with severe traumatic brain injury: a multicenter study","volume":"29","year":"2014","journal-title":"J Head Trauma Rehabil"},{"issue":"1","key":"bib19-20250621","first-page":"31","article-title":"Emotional and behavioral dyscontrol after traumatic brain injury","volume":"37","year":"2014","journal-title":"Psychiatr Clin"},{"issue":"2","key":"bib20-20250621","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/j.1365-2710.2005.00628.x","article-title":"Amantadine for traumatic brain injury: does it improve cognition and reduce agitation?","volume":"30","year":"2005","journal-title":"J Clin Pharm Ther"},{"issue":"2","key":"bib21-20250621","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.annemergmed.2004.03.028","article-title":"Comparison of consciousness level assessment in the poisoned patient using the alert\/verbal\/painful\/unresponsive scale and the Glasgow Coma Scale","volume":"44","year":"2004","journal-title":"Ann Emerg Med"},{"issue":"1","key":"bib23-20250621","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/j.1365-2044.2004.03526.x","article-title":"Simple bedside assessment of level of consciousness: comparison of two simple assessment scales with the Glasgow Coma scale","volume":"59","year":"2004","journal-title":"Anaesthesia"},{"issue":"10","key":"bib24-20250621","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1164\/rccm.2107138","article-title":"The Richmond Agitation\u2013Sedation Scale: validity and reliability in adult intensive care unit patients","volume":"166","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"bib25-20250621","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1097\/00001199-200307000-00005","article-title":"Rehabilitation pharmacology: bridging laboratory work to clinical application","volume":"18","year":"2003","journal-title":"J Head Trauma Rehabil"},{"key":"bib26-20250621","first-page":"119","article-title":"Targeting dopamine in acute traumatic brain injury","volume":"2","year":"2010","journal-title":"Open Drug Disc J"},{"issue":"1","key":"bib28-20250621","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1007\/s12028-020-00986-4","article-title":"Amantadine and modafinil as neurostimulants following acute stroke: a retrospective study of intensive care unit patients","volume":"34","year":"2021","journal-title":"Neurocrit Care"},{"issue":"10","key":"bib29-20250621","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/0003-9993(93)90072-I","article-title":"Amantadine-induced coma","volume":"74","year":"1993","journal-title":"Arch Phys Med Rehabil"},{"issue":"3","key":"bib30-20250621","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/0014-2999(85)90564-3","article-title":"Pharmacological changes in dopaminergic systems induced by long-term administration of amantadine","volume":"110","year":"1985","journal-title":"Eur J Pharmacol"},{"key":"bib31-20250621","first-page":"23","article-title":"Opportunities for neuroprotective drugs in clinical management of head injury","volume":"11","year":"1993","journal-title":"J Emerg Med"},{"issue":"7","key":"bib32-20250621","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1038\/sj.npp.1301534","article-title":"Modafinil: a review of neurochemical actions and effects on cognition","volume":"33","year":"2008","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"bib33-20250621","first-page":"1","article-title":"Effect of modafinil administration on the level of consciousness in patients with brain injuries of moderate severity","volume":"24","year":"2019","journal-title":"Trauma Mon"},{"issue":"4","key":"bib34-20250621","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/j.neuroscience.2005.02.003","article-title":"Dopaminergic\u2013adrenergic interactions in the wake promoting mechanism of modafinil","volume":"132","year":"2005","journal-title":"Neuroscience"},{"issue":"13","key":"bib35-20250621","doi-asserted-by":"crossref","first-page":"2883","DOI":"10.1097\/00001756-199709080-00016","article-title":"The antinarcoleptic drug modafinil increases glutamate release in thalamic areas and hippocampus","volume":"8","year":"1997","journal-title":"Neuroreport"},{"issue":"2","key":"bib36-20250621","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0304-3940(98)00629-6","article-title":"The effects of modafinil on striatal, pallidal and nigral GABA and glutamate release in the conscious rat: evidence for a preferential inhibition of striato-pallidal GABA transmission","volume":"253","year":"1998","journal-title":"Neurosci Lett"},{"issue":"4","key":"bib37-20250621","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/S0893-133X(98)00085-2","article-title":"The vigilance promoting drug modafinil increases extracellular glutamate levels in the medial preoptic area and the posterior hypothalamus of the conscious rat: prevention by local GABAA receptor blockade","volume":"20","year":"1999","journal-title":"Neuropsychopharmacology"},{"issue":"1\u20132","key":"bib38-20250621","first-page":"201","article-title":"6-Hydroxy-dopamine treatment counteracts the reduction of cortical GABA release produced by the vigilance promoting drug modafinil in the awake freely moving guinea-pig","volume":"171","year":"1994","journal-title":"Neurosci Lett"},{"issue":"20","key":"bib39-20250621","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1212\/WNL.0b013e3181fd62a2","article-title":"Modafinil ameliorates excessive daytime sleepiness after traumatic brain injury","volume":"75","year":"2010","journal-title":"Neurology"},{"issue":"5","key":"bib40-20250621","first-page":"486","article-title":"Evaluation of outcomes in patients receiving amantadine to improve alertness after traumatic Brain injury","volume":"56","year":"2020","journal-title":"Hosp Pharm"},{"issue":"5","key":"bib41-20250621","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1080\/13803390903201769","article-title":"Modafinil effects on cognitive function in HIV+ patients treated for fatigue: a placebo controlled study","volume":"32","year":"2010","journal-title":"J Clin Exp Neuropsychol"},{"issue":"18","key":"bib42-20250621","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1200\/JCO.2013.54.4346","article-title":"Modafinil for the treatment of fatigue in lung cancer: results of a placebo-controlled, double-blind, randomized trial","volume":"32","year":"2014","journal-title":"J Clin Oncol"},{"issue":"1","key":"bib43-20250621","first-page":"1","article-title":"Efficacy and safety of dopamine agonists in traumatic brain injury: a systematic review of randomized controlled trials","volume":"15","year":"2011","journal-title":"Crit Care"},{"issue":"10","key":"bib44-20250621","doi-asserted-by":"crossref","first-page":"2242","DOI":"10.1007\/s10620-008-0613-3","article-title":"Modafinil in the treatment of debilitating fatigue in primary biliary cirrhosis: a clinical experience","volume":"54","year":"2009","journal-title":"Dig Dis Sci"},{"issue":"11","key":"bib45-20250621","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1177\/0885066619841603","article-title":"Stimulant therapy in acute traumatic brain injury: prescribing patterns and adverse event rates at 2 level 1 trauma centers","volume":"35","year":"2020","journal-title":"J Intensive Care Med"},{"issue":"8","key":"bib46-20250621","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1080\/02699052.2018.1476733","article-title":"The effects of amantadine on traumatic brain injury outcome: a double-blind, randomized, controlled, clinical trial","volume":"32","year":"2018","journal-title":"Brain Inj"},{"issue":"7\u20138","key":"bib47-20250621","first-page":"1475","article-title":"Biochemical and clinical improvement of cytotoxic state by amantadine sulphate","volume":"26","year":"2006","journal-title":"Cell Mol Neurobiol"},{"issue":"9","key":"bib48-20250621","first-page":"604","article-title":"From vegetative state to participation: amantadine as a trigger of the rehabilitation program [in Portuguese]","volume":"33","year":"2020","journal-title":"Acta Medica Portuguesa"},{"issue":"4","key":"bib49-20250621","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1007\/s00702-004-0112-4","article-title":"The outcome of patients with severe head injuries treated with amantadine sulphate","volume":"111","year":"2004","journal-title":"J Neural Transm (Vienna)"},{"issue":"2","key":"bib50-20250621","doi-asserted-by":"crossref","first-page":"1","DOI":"10.21608\/zumj.2016.4639","article-title":"Amantadine sulfate effects on the outcome of patients with moderate and severe traumatic brain injury","volume":"22","year":"2016","journal-title":"Zagazig Univ Med J"},{"issue":"3","key":"bib51-20250621","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.jemermed.2004.11.016","article-title":"Improved neurological function after amantadine treatment in two patients with brain injury","volume":"28","year":"2005","journal-title":"J Emerg Med"},{"issue":"7","key":"bib52-20250621","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1080\/026990598122386","article-title":"Amantadine: a potential treatment for the minimally conscious state","volume":"12","year":"1998","journal-title":"Brain Inj"},{"issue":"June","key":"bib53-20250621","first-page":"1867","article-title":"Comparative study between the efficacy of amantadine sulphate versus erythropoietin on traumatic brain injury","volume":"86","year":"2018","journal-title":"Med J Cairo Univ"},{"key":"bib54-20250621","doi-asserted-by":"crossref","first-page":"1179069518824851","DOI":"10.1177\/1179069518824851","article-title":"The effect of oral administration of amantadine on neurological outcome of patients with diffuse axonal injury in ICU","volume":"13","year":"2019","journal-title":"J Exp Neurosci"},{"key":"bib55-20250621","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.21608\/mjcu.2018.56758","article-title":"The value of using amantadine upon improving conscious level in isolated head trauma patients guided by Glasgow Coma Scale and Bispectral Index","volume":"86","year":"2018","journal-title":"Med J Cairo Univ"},{"issue":"3\u20134","key":"bib56-20250621","first-page":"11","article-title":"Modafinil augmentation therapy in patient with traumatic brain injury","volume":"14","year":"2017","journal-title":"Innovations in clinical neuroscience"},{"issue":"9","key":"bib57-20250621","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1056\/NEJMoa1102609","article-title":"Placebo-controlled trial of amantadine for severe traumatic brain injury","volume":"366","year":"2012","journal-title":"New Engl J Med"},{"issue":"3","key":"bib58-20250621","first-page":"453","article-title":"Predictors of outcome in prolonged posttraumatic disorders of consciousness and assessment of medication effects: a multicenter study","volume":"86","year":"2005"},{"issue":"1","key":"bib60-20250621","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S1474-4422(18)30415-0","article-title":"Global, regional, and national burden of traumatic brain injury and spinal cord injury, 1990\u20132016: a systematic analysis for the Global Burden of Disease Study 2016","volume":"18","year":"2019","journal-title":"Lancet Neurology"},{"key":"bib61-20250621","first-page":"1","article-title":"National Hospital Care Survey Demonstration Projects: traumatic Brain injury","volume":"97","year":"2016","journal-title":"Natl Health Stat Rep"},{"issue":"1","key":"bib62-20250621","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1097\/01.ccm.0000552505.24300.aa","article-title":"1767: arousal agents given to traumatic brain injury patients in the ICU: a four-year retrospective study","volume":"47","year":"2019","journal-title":"Crit Care Med"}],"container-title":["Clinical Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/WNF.0000000000000577","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T17:05:00Z","timestamp":1750525500000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/WNF.0000000000000577"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,19]]},"references-count":57,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/wnf.0000000000000577","relation":{},"ISSN":["1537-162X","0362-5664"],"issn-type":[{"value":"1537-162X","type":"electronic"},{"value":"0362-5664","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10,19]]}}}